These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16053446)

  • 1. The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope.
    Harada S
    Biochem J; 2005 Nov; 392(Pt 1):191-9. PubMed ID: 16053446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulator.
    Harada S; Yokomizo K; Monde K; Maeda Y; Yusa K
    Cell Microbiol; 2007 Jan; 9(1):196-203. PubMed ID: 17222192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies decrease the envelope fluidity of HIV-1.
    Harada S; Monde K; Tanaka Y; Kimura T; Maeda Y; Yusa K
    Virology; 2008 Jan; 370(1):142-50. PubMed ID: 17900650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of membrane fluidity on human immunodeficiency virus type 1 entry.
    Harada S; Yusa K; Monde K; Akaike T; Maeda Y
    Biochem Biophys Res Commun; 2005 Apr; 329(2):480-6. PubMed ID: 15737612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 activation of HIV fusion.
    Sattentau QJ
    Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Düzgünes N
    Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O; Hammache D; Fantini J; Yahi N
    Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
    Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
    Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorption and infectivity of human immunodeficiency virus type 1 are modified by the fluidity of the plasma membrane for multiple-site binding.
    Harada S; Akaike T; Yusa K; Maeda Y
    Microbiol Immunol; 2004; 48(4):347-55. PubMed ID: 15107546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cepharanthine inhibited HIV-1 cell-cell transmission and cell-free infection via modification of cell membrane fluidity.
    Matsuda K; Hattori S; Komizu Y; Kariya R; Ueoka R; Okada S
    Bioorg Med Chem Lett; 2014 May; 24(9):2115-7. PubMed ID: 24704028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of human immunodeficiency virus type 1 (HIV-1) infection via increased membrane fluidity by a cationic polymer.
    Owada T; Miyashita Y; Motomura T; Onishi M; Yamashita S; Yamamoto N
    Microbiol Immunol; 1998; 42(2):97-107. PubMed ID: 9572041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness.
    Fredericksen BL; Whitt MA
    Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV and SIV gp120 binding does not predict coreceptor function.
    Baik SS; Doms RW; Doranz BJ
    Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry.
    Mirsaliotis A; Nurkiyanova K; Lamb D; Woof JM; Brighty DW
    J Virol; 2007 Jun; 81(11):6019-31. PubMed ID: 17376912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
    Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
    Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effects of Glycyrrhiza species.
    Fiore C; Eisenhut M; Krausse R; Ragazzi E; Pellati D; Armanini D; Bielenberg J
    Phytother Res; 2008 Feb; 22(2):141-8. PubMed ID: 17886224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.